Home › Funds › Lynx1 Capital Management LP › VYNE
Lynx1 Capital Management LP position in VYNE
VYNE THERAPEUTICS INC
Lynx1 Capital Management LP reported holding 1,628,700 shares of VYNE (VYNE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$1.1M, representing 0.12% of its reported portfolio and ranking #14 among its reported holdings. Lynx1 Capital Management LP has disclosed VYNE holdings in 4 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Lynx1 Capital Management LP's VYNE position evolved
Lynx1 Capital Management LP first disclosed a stake in VYNE in Q2 2024 at 16,194 shares (US$32K). The position peaked in Q2 2026 at 1,628,700 shares, worth US$1.1M. Across 4 filings, Lynx1 Capital Management LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 1,628,700 shares valued at US$1.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 16.19K | $31.90K | New |
| Q3 2024 | 16.19K | $30.45K | Hold |
| Q1 2026 | 1.63M | $973.15K | New |
| Q2 2026 | 1.63M | $1.06M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VYNE and 13F data
VYNE (VYNE THERAPEUTICS INC) is a company whose sector is not yet classified in our data. 28 other funds we track also report a position in VYNE — the largest reported positions include KVP Capital Advisors, LP (US$326K), SUPERSTRING CAPITAL MANAGEMENT LP (US$40K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VYNE
- KVP Capital Advisors, LP 500.55K sh · $325.71K · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 61.27K sh · $39.87K · Q2 2026
More on Lynx1 Capital Management LP
FAQ
How long has Lynx1 Capital Management LP held VYNE?
Lynx1 Capital Management LP has disclosed VYNE holdings in 4 of the last 9 reported quarters, going back to Q2 2024.
What is Lynx1 Capital Management LP's current position in VYNE?
As of Q2 2026, Lynx1 Capital Management LP holds 1.63M shares of VYNE (VYNE THERAPEUTICS INC), valued at $1.06M, representing 0.12% of its reported portfolio and ranking #14.
Has Lynx1 Capital Management LP been buying or selling VYNE?
In the latest 13F filing (Q2 2026), Lynx1 Capital Management LP held unchanged its position in VYNE. The position peaked in Q2 2026 at 1.63M shares.
Which other funds hold VYNE?
Other major institutional holders of VYNE include KVP Capital Advisors, LP, SUPERSTRING CAPITAL MANAGEMENT LP, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.